Skip to main content
Premium Trial:

Request an Annual Quote

Challenges, Commitment

This week, The New York Times' Gina Kolata spoke with four women scientists at the top of their fields to get a feel for "their lives as scientists, the joys and struggles of research, and the specific challenges women in science face." Among the four is the University of Washington's Mary-Claire King, who tells the Times she believes that, for female researchers, "the choke point is going from a postdoc to an assistant professorship to a tenure-track position." After that, she says, it's been her experience that "the largest remaining obstacle is how to integrate family life with the life of a scientist." For that, King says an "institutional commitment" to subsidized, on-campus child care is critical. "… At institutions where it is assumed that you will make your own arrangements, women do less well," she tells Kolata.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.